Merus’s big bispecific test approaches
Hopes are high for petosemtamab head and neck data at ASCO, but what does a win look like?
Hopes are high for petosemtamab head and neck data at ASCO, but what does a win look like?
Abstract titles reveal some of ASCO’s key datasets.
Merus still hopes for a future for MCLA-129, but the doors are closing.
Flaura2 takes centre stage, while Trodelvy and dato square off in PD-1 combo trials.